MDR1 reversal agents, such as verapamil and cyclosporine A, have been developed to inhibit the efflux activity of MDR1 and restore the sensitivity of cancers to chemotherapeutic drugs (Szakacs et al., 2006). The gene discussed is ABCB1; the disease is cancer.